Glutamic Acid
Research News and Information

Sunday, November 22, 2009

Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells.

29 Nov 2009 Bradykinin (BK) is a potent modulator of biological processes in the retina, and retinal pigment epithelial cells (RPE) and the regulation of glutamate are believed to be important in the pathogenesis of diabetic retinopathy. However, the mechanism ... Read more...

Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability.

2 Nov 2009 The effects of lifelong, moderate excess release of glutamate (Glu) in the CNS have not been previously characterized. We created a transgenic (Tg) mouse model of lifelong excess synaptic Glu release in the CNS by introducing the gene for glutamate ... Read more...

Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in patients with subarachnoid hemorrhage. Clinical article.

30 Oct 2009 OBJECT: The aim of this study was to explore the relationship between hemodynamics (intracranial and systemic) and brain tissue energy metabolism, and between hemodynamics and glutamate (Glt)-glutamine (Gln) cycle activity. METHODS: Brain ... Read more...

Latest indexed articles for 'Glutamic Acid'

These are the very latest articles for this heading:

• Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. 29 Nov 2009
• Transgenic expression of Glud1 (glutamate dehydrogenase 1) in neurons: in vivo model of enhanced glutamate release, altered synaptic plasticity, and selective neuronal vulnerability. 2 Nov 2009
• Relationship between intracranial hemodynamics and microdialysis markers of energy metabolism and glutamate-glutamine turnover in patients with subarachnoid hemorrhage. Clinical article. 30 Oct 2009
• Schizophrenia; from structure to function with special focus on the mediodorsal thalamic prefrontal loop. 30 Oct 2009
• Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons. 30 Oct 2009
• Volatile anesthetics attenuate oxidative stress-reduced activity of glutamate transporter type 3. 30 Oct 2009
• Astrocyte-neuron interactions: implications for epilepsy. 18 Oct 2009
• PIKfyve regulates CaV1.2 degradation and prevents excitotoxic cell death. 17 Oct 2009
• Fast synaptic subcortical control of hippocampal circuits. 14 Oct 2009
• Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. 12 Oct 2009
• Input-specific intrasynaptic arrangements of ionotropic glutamate receptors and their impact on postsynaptic responses. 12 Oct 2009
• Chronic nicotine selectively enhances alpha4beta2* nicotinic acetylcholine receptors in the nigrostriatal dopamine pathway. 5 Oct 2009
• Supplement may ease compulsive hair pulling. 29 Sep 2009
• Excitotoxic motoneuron degeneration induced by glutamate receptor agonists and mitochondrial toxins in organotypic cultures of chick embryo spinal cord. 29 Sep 2009
• Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine. 29 Sep 2009
• Wireless Instantaneous Neurotransmitter Concentration System-based amperometric detection of dopamine, adenosine, and glutamate for intraoperative neurochemical monitoring. 29 Sep 2009
• Endothelial protein C receptor is expressed in rat cortical and hippocampal neurons and is necessary for protective effect of activated protein C at glutamate excitotoxicity. 23 Sep 2009
• Titin phosphorylation: myocardial passive stiffness regulated by the intracellular giant. 23 Sep 2009
• Glutamate controls growth rate and branching of dopaminergic axons. 21 Sep 2009
• AMPA receptor ligand binding domain mobility revealed by functional cross linking. 21 Sep 2009

See a longer list of these articles.

Technical information about 'Glutamic Acid'

Definition: A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM.

Chemical name: L-Glutamic acid

Registry Number: 56-86-0

Descriptor UI: D018698

Alternative terms: Glutamic Acid; L-Glutamic Acid; L Glutamic Acid; Glutamate; L-Glutamate; L Glutamate; Glutamic Acid, (D)-Isomer; D-Glutamate; D Glutamate;

Related Mesh Headings: Receptors, Glutamate;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications;

Tree Number: D12.125.067.750; D12.125.119.450; D12.125.427.300;

Online Note: use GLUTAMIC ACID (NM) to search GLUTAMIC ACID 1981-94

History Note: 95; was GLUTAMIC ACID (NM) 1981-94

Technical Notes: /agon = EXCITATORY AMINO ACID AGONISTS; /antag = EXCITATORY AMINO ACID ANTAGONISTS